Research Topics
| Paul G BarnettSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophreniaPaul G Barnett
Health Economics Resource Center, VA Cooperative Studies Program, VA Palo Alto Health Care System, Menlo Park, CA 94025, USA
J Clin Psychiatry 73:696-702. 2012..The effect of long-acting injectable (LAI) risperidone on health care costs was determined in a multisite clinical trial...- The cost-effectiveness of a smoking cessation program for out-patients in treatment for depressionPaul G Barnett
Department of Psychiatry, University of California, San Francisco, CA, USA
Addiction 103:834-40. 2008..The cost-effectiveness of programs for psychiatric patients may be affected by differences in cost, efficacy, survival and quality of life. We evaluated cost-effectiveness of a program for smokers being treated for depression... 
Effect of incentives for medication adherence on health care use and costs in methadone patients with HIVPaul G Barnett
Veterans Affairs Health Economics Resource Center, 795 Willow Rd 152 MPD, VA Palo Alto Health Care System, Menlo Park, CA 94025, USA
Drug Alcohol Depend 100:115-21. 2009..The potential benefits of anti-retroviral therapy for HIV is not fully realized because of difficulties in adherence with demanding treatment regimens, especially among injection drug users...- Comparison of costs and utilization among buprenorphine and methadone patientsPaul G Barnett
Veterans Affairs Health Economics Resource Center and Department of Health Research and Policy, Stanford University, CA, USA
Addiction 104:982-92. 2009..The economic impacts of buprenorphine adoption by the US Veterans Health Administration (VHA) were examined... - Cost and outcomes of patients with solitary pulmonary nodules managed with PET scansPaul G Barnett
Health Economics Resource Center, 795 Willow Rd 152, Menlo Park, CA 94025, USA
Chest 137:53-9. 2010..No prior study to our knowledge has observed the cost of managing solitary pulmonary nodules of patient groups defined by PET scan results... - An improved set of standards for finding cost for cost-effectiveness analysisPaul G Barnett
Health Economics Resource Center, US Department of Veterans Affairs and Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
Med Care 47:S82-8. 2009..Guidelines are not specific enough with respect to costing methods, however... - The cost of concordance with opiate substitution treatment guidelinesPaul G Barnett
VA Health Economics Resource Center HERC, VA Palo Alto Health Care System, Menlo Park, CA 94025, USA
J Subst Abuse Treat 39:141-9. 2010..Annual mortality was 3.0% and did not differ by type of care. Preference-based quality of life significantly improved only at highly concordant sites... - How do clinical trial participants compare to other patients with schizophrenia?Paul G Barnett
Health Economics Resource Center, VA Cooperative Studies Program, VA Palo Alto Health Care System, 795 Willow Road 152, Menlo Park, CA 94025, USA
Schizophr Res 130:34-9. 2011..We considered if the trial participants were representative of the targeted group of high-utilization patients with poor adherence to anti-psychotics... - Determinants of the cost of health services used by veterans with HIVPaul G Barnett
VA Health Economics Resource Center, 795 Willow Road, Menlo Park, CA, USA
Med Care 49:848-56. 2011..The effect of adherence, treatment failure, and comorbidities on the cost of HIV care is not well understood... 
Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomizationPaul G Barnett
Department of Psychiatry, University of California, San Francisco, CA, USA
Addiction 101:1797-804. 2006..To conduct an economic evaluation of the first 6 months' trial of treatment vouchers and case management for opioid-dependent hospital patients...- Prevalence and costs of chronic conditions in the VA health care systemWei Yu
VA HSR and D Health Economics Resource Center, Center for Health Policy, Center for Primary Care and Outcomes Research, Stanford University, USA
Med Care Res Rev 60:146S-167S. 2003..2 million) of VA health care users had 3 or more of the 29 chronic conditions. These individuals accounted for 73 percent of the total cost. Overall, VA health care users have more chronic diseases than the general population... - Average cost of VA rehabilitation, mental health, and long-term hospital staysWei Yu
VA HSR and D Health Economics Resource Center, Stanford University, USA
Med Care Res Rev 60:40S-53S. 2003..Encounter-level costs were then calculated by multiplying the average per diem cost by the number of days of stay in the fiscal year. The national cost estimates are more reliable than the local cost estimates... - The relationships among age, chronic conditions, and healthcare costsWei Yu
Health Economics Resource Center, VA Palo Alto Health Care System, Menlo Park, CA 94025, USA
Am J Manag Care 10:909-16. 2004..To learn how age and chronic illness affect costs in the Veterans Affairs healthcare system... - Determination of VA health care costsPaul G Barnett
VA HSR and D Health Economics Resource Center, VA Cooperative Studies Program, Stanford University, USA
Med Care Res Rev 60:124S-141S. 2003..The Health Economics Resource Center uses pseudo-bill and cost regression methods to create an encounter-level database of VA costs. Researchers are also beginning to use the VA activity-based cost allocation system... - Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trialVilija R Joyce
VA Palo Alto Health Care System, VA Cooperative Studies Program Coordinating Center, VA HSR and D Health Economics Resource Center, Menlo Park, California 94025, USA
Med Decis Making 32:70-82. 2012..The effect of antiretroviral therapy (ART) interruption or intensification on health-related quality of life (HRQoL) in advanced HIV patients is unknown... - Direct measurement of health care costsMark W Smith
Health Economics Resource Center, Center for Health Care Evaluation, Veterans Affairs Palo Alto Health Care System, USA
Med Care Res Rev 60:74S-91S. 2003..A parsimonious data collection effort is desirable, although study hypotheses and perspective should guide the endeavor. Special reference is made to data sources within the Department of Veterans Affairs (VA) health care system... - Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV diseaseVilija R Joyce
Veterans Affairs Palo Alto Health Care System, Veterans Affairs Cooperative Studies Program Coordinating Center, Menlo Park, CA 94025, USA
J Acquir Immune Defic Syndr 50:27-36. 2009..To assess and compare alternative approaches of measuring preference-based health-related quality of life (HRQoL) in treatment-experienced HIV patients and evaluate their association with health status and clinical variables... - Estimating the costs of VA ambulatory careCiaran S Phibbs
VA HSR and D Health Economics Resource Center, VA Cooperative Studies Program, Department of Health Research and Policy, Center for Primary Care and Outcomes Research, Stanford University, USA
Med Care Res Rev 60:54S-73S. 2003..They are potentially useful for any system that does not generate billing data, when CPT codes are simpler to collect than billing data, or when there is a need to standardize cost estimates across data sources... - Spending for specialized mental health treatment in The VA: 1995-2001Shuo Chen
Health Economics Resource Center, Veterans Affairs Palo Alto Health Care System, Menlo Park, California, USA
Health Aff (Millwood) 22:256-63. 2003..Overall, the VA reduced the average cost (per VA user) of specialized mental health care by 22 percent while it increased the number of users of these services by 35 percent... - Using average cost methods to estimate encounter-level costs for medical-surgical stays in the VATodd H Wagner
VA HSR and D Health Economics Resource Center, Stanford University, USA
Med Care Res Rev 60:15S-36S. 2003..They discuss the method's limitations and application in other health care systems... - Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxificationCarmen L Masson
University of California, San Francisco, USA
Addiction 99:718-26. 2004..To compare the cost and cost-effectiveness of methadone maintenance treatment and 180-day methadone detoxification enriched with psychosocial services... - Randomized trial of drug abuse treatment-linkage strategiesJames L Sorensen
Department of Psychiatry, University of California, San Francisco, 94110, USA
J Consult Clin Psychol 73:1026-35. 2005..Case management and vouchers can be valuable in health settings to link substance abusers with medical problems to drug abuse treatment... - Reducing costs of acute care for ambulatory care-sensitive medical conditions: the central roles of comorbid mental illnessJean Yoon
Health Economics Resource Center, VA Palo Alto Health Care System, Menlo Park, CA 94025, USA
Med Care 50:705-13. 2012..This study aims to identify whether mental illness and other characteristics of primary care patients are related to risk for an acute event for an ambulatory care-sensitive condition (ACSC)... - Characteristics of Asian and Pacific Islanders admitted to U.S. drug treatment programs in 2005Wynnie Wong
Treatment Research Center, Department of Psychiatry, University of California, San Francisco 94143 0984, USA
Public Health Rep 125:250-7. 2010..We determined how Asian and Pacific Islanders (APIs) differ from clients from other ethnic groups in regard to drug use and admissions to drug treatment programs... - Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severityShuo Chen
Center for Health Care Evaluation, Department of Veterans Affairs Health Care System, Menlo Park, CA 94025, USA
J Subst Abuse Treat 31:95-105. 2006..Research is needed to establish standards by which to judge whether the added benefits of high-intensity acute care justify the extra costs... - PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancerViswam S Nair
Stanford University School of Medicine, Division of Pulmonary and Critical Care Medicine, 300 Pasteur Dr, A283, Stanford, CA 94305, USA
Chest 137:1150-6. 2010..Our objective was to examine the association between (18)F-fluorodeoxyglucose (FDG) uptake on PET scan and prognosis in patients with surgically treated, clinical stage IA non-small cell lung cancer (NSCLC)... - The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centersMagdalena Berger
VA Palo Alto Health Care System, VA Cooperative Studies Program Coordinating Center, VA HSR and D Health Economics Resource Center, Menlo Park, CA 94025, USA
AJR Am J Roentgenol 181:359-65. 2003..Because both PET and cyclotron facilities have high fixed costs, increasing the number of scans obtained and the number of FDG doses manufactured may lead to a decrease in unit costs... - Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patientsKevin T Stroupe
Cooperative Studies Program Coordinating Center, Hines VA Hospital, PO Box 5000 151H, Hines, IL 60141, USA
Circulation 114:1251-7. 2006..The present study examined the cost-effectiveness of PCI versus CABG for these high-risk patients... - Long-acting risperidone and oral antipsychotics in unstable schizophreniaRobert A Rosenheck
Veterans Affairs VA New England Mental Illness, Research Education and Clinical Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
N Engl J Med 364:842-51. 2011.... - Challenges in the design and conduct of controlled clinical effectiveness trials in schizophreniaRobert A Rosenheck
Veterans Affairs VA Connecticut Healthcare System, West Haven, CT, USA
Clin Trials 8:196-204. 2011.... - Longer length of stay is not associated with better outcomes in VHA's substance abuse residential rehabilitation treatment programsAlex H S Harris
Center for Health Care Evaluation, VA Palo Alto Health Care System, Stanford University School of Medicine, Menlo Park, CA 94025, USA
J Behav Health Serv Res 39:68-79. 2012..05). Therefore, in VHA SARRTPs, ALOS greater than 90 days cannot be justified by the substance use disorder severity of the patients served or the magnitude of the clinical improvement observed... - Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trialPaul G Barnett
VA Palo Alto Health Care System, Palo Alto, Calif, USA
Circulation 105:680-4. 2002.... - Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodulesMichael K Gould
Pulmonary Section, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, California 94304, USA
Ann Intern Med 138:724-35. 2003..Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) is a potentially useful but expensive test to diagnose solitary pulmonary nodules... - Determinants of cost among people who died in VA nursing homesWei Yu
VA Health Economics Resource Center
Med Care Res Rev 63:477-98. 2006..Incorporating illness into models that predict future demand for nursing home use provides greater precision than using age alone, especially as diseases and their treatments change through time...